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Aim To determine the incidence of possible transfusion-
related acute lung injury (TRALI) and related risk factors in 
cardiac surgery patients.
Methods A single-center prospective cohort study was 
conducted from January 2009 to March 2010 at the Za-
greb University Hospital Center, Croatia. Patient-, transfu-
sion-, and surgery-related data were collected. The study 
included 262 patients who were observed for respiratory 
worsening including measurements of arterial oxygen sat-
uration (SaO2), fraction of inspired oxygen (FiO2), and par-
tial pressure of arterial oxygen (PaO2). Possible TRALI was 
defined according to the Toronto Consensus Conference 
definition broadened for 24-hour post-transfusion. This co-
hort was divided in two groups. TRALI group included 32 
participants with diagnosis of TRALI and the control group 
included 220 patients with or without respiratory worsen-
ing, but with no signs of ALI.
Results Possible TRALI was observed in 32 (12.2%) patients. 
Compared with the control group, possible TRALI patients 
had higher American Association of Anesthesiology scores, 
higher rate of respiratory comorbidity (43.8% vs 15.5%), and 
required more red blood cells (median 4, range [2.5-6] vs 2 
[1-3]), plasma (5 [0-6] vs 0 [0-2]), and platelet units (0 [0-8] 
vs 0 [0-0]) (P < 0.001 all). Risk factors for possible TRALI were 
total number of transfused blood units (odds ratio [OR] 
1.23; 95% confidence interval [CI] 1.10-1.37) and duration of 
cardiopulmonary bypass (OR 1.08; 95% CI 1.05-1.11). Post-
transfusion PaO2/FiO2 ratio was significantly decreased in 
possible TRALI patients and significantly increased in trans-
fused controls without acute lung injury.
Conclusion We observed a higher rate of possible TRALI 
cases than in other studies on cardiac surgery patients. Se-
rial monitoring of PaO2/FiO2 ratio and detection of its post-
transfusion worsening aids in identification of possible 
TRALI cases.
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Patients undergoing cardiac surgery often require sup-
portive blood transfusion therapy. The rates of allogeneic 
blood transfusions are high, varying from 40% to 90% (1-3). 
This may be attributed to the fact that anemia is an inde-
pendent risk factor for higher morbidity and mortality and 
that cardiac surgery patients may have a higher transfu-
sion threshold (4,5). On the other hand, recent studies have 
shown a worse outcome in patients who received trans-
fusion (2,6). Significant outcome improvement has been 
clearly demonstrated after implementation of the blood 
use guidelines of the American Association for Thoracic 
Surgery (7). In addition, due to the acquired disorder of he-
mostasis with the use of cardiopulmonary bypass, many 
patients receive plasma and platelet transfusion.
Although transfusion therapy can be lifesaving, it may also 
be life-threatening if patients develop transfusion-related 
lung injury (TRALI). TRALI is a clinical syndrome character-
ized by the onset of respiratory distress temporally related 
to transfusion of any blood component. TRALI is consid-
ered the leading cause of transfusion-related morbidity 
and mortality (8-10). This serious adverse event of trans-
fusion is underreported and underestimated (11-14). One 
of the main reasons is reduced awareness of TRALI among 
clinicians. The definition seems straightforward but clinical 
presentation of TRALI is indistinguishable from acute respi-
ratory distress syndrome (ARDS) due to other causes. Cases 
of TRALI remain unnoticed or misdiagnosed because of a 
diversity of its clinical symptoms, as well as the absence of 
specific disease markers and diagnostic tests (15).
When applying standard definitions of TRALI, a unique 
challenge are patients undergoing cardiac surgery (10,16-
18). Cardiac surgery carries multiple risk factors for ARDS/
ALI and often leads to TRALI being misdiagnosed. To iden-
tify such cases, the term possible TRALI has been coined, 
which allows for the presence of alternative risk factors for 
acute respiratory worsening (10).
There is limited clinical evidence as to why only a subset 
of cardiothoracic surgical patients experience worsening 
of respiratory function after exposure to blood transfu-
sions. There is also a knowledge gap on respiratory com-
plications occurring post-transfusion (15,19). In the past, 
TRALI has been only sporadically reported in Croatia and 
so far there are no published clinical studies. Therefore, 
we aimed to evaluate whether transfusion was associated 
with a worsening respiratory status in cardiothoracic sur-
gical patients in Croatia. Previous studies provided some 
data on the prevalence and risk factors for classic TRALI, 
which by definition develops within 6 hours post-transfu-
sion (10). Since some studies have shown that critically ill 
patients are at an increased risk of ALI up to 72 hours post-
transfusion, we investigated whether the same was true for 
TRALI (19). This is also the first study that investigated the 
incidence of TRALI for a period up to 24 hours post-trans-
fusion to identify not only the classic but also the delayed 
possible TRALI cases. Respiratory worsening is routinely re-
corded in intensive care unit (ICU) and passive reports of 
TRALI are generally imprecise. We used a prospective study 
design so we could connect all measured respiratory de-
teriorations with previous transfusions and exclude other 
differential diagnoses to identify possible TRALI. In order to 
better identify connections of respiratory worsening with 
previous transfusions, consecutive measurements of respi-
ratory status (including measurements of arterial oxygen 
saturation [SaO
2]), fraction of inspired oxygen [FiO2], par-
tial pressure of oxygen in arterial blood [PaO2]) were per-
formed in a controlled setting, thus facilitating identifica-
tion of possible TRALI cases.
PaTienTs and MeTHods
A total of 756 consecutive patients who had undergone 
cardiothoracic surgery with cardiopulmonary bypass at 
the Zagreb University Hospital Center were screened for 
inclusion criteria between January 2009 and March 2010. 
Exclusion criteria were no transfusion, age <18, ICU stay 
<24 hours, no approval for the study, and ICU readmission 
(Figure 1). The study protocol was approved by the hospi-
tal Ethics Committee and a written informed consent was 
obtained from each patient before the surgery.
Our cohort included 262 transfused patients (171 male and 
91 female) who signed informed consent, had undergone 
cardiothoracic surgery, and had received at least one of the 
blood components including red blood cells (RBC), plasma, 
or platelets. This cohort was divided in two groups. TRALI 
group included 32 participants with diagnosis of TRALI and 
the control group included 220 patients with or without 
respiratory worsening, but with no signs of ALI (Figure 1). 
Ten patients were excluded from this group because of a 
possible overlap with the TRALI group. The enrolled pa-
tients were closely observed for respiratory worsening and 
measurements of arterial oxygen saturation (SaO2), fraction 
of inspired oxygen (FiO2), and partial pressure of oxygen in 
arterial blood (PaO2) were obtained during as well as im-
mediately after the surgery, and then every 6 hours for 
the next 24 hours. PaO2 was measured from an arte-
rial catheter blood sample. Frontal chest radiograph, 
CLINICAL SCIENCE140 Croat Med J. 2014;55:138-45
www.cmj.hr
apart from the routine radiographic procedures, was done 
in all patients in whom respiratory worsening was ob-
served. A pulmonary artery catheter was inserted as part 
of the standard perioperative monitoring.
TRALI was determined according to the Toronto Consen-
sus Conference definition (10). To be classified as TRALI, pa-
tients had to conform to two sets of criteria. First, they had 
to have a diagnosis of acute lung injury (ALI) (nowadays 
classified according to Berlin definition as mild ARDS) (20), 
characterized by acute onset, lack of clinical evidence of 
left atrial hypertension, bilateral infiltrates on frontal chest 
radiograph, and PaO2/FiO2 ratio ≤300 mm Hg regardless of 
positive end-expiratory pressure level or oxygen saturation 
of <90% when the patient is breathing room air. Second, 
exclusion of differential diagnoses was required (such as 
acute coronary syndrome, transfusion-associated cardiac 
overload, newly emerging sepsis, and pneumonia). Since 
an alternative ARDS risk factor (such as aspiration, pneu-
monia, lung contusion, drowning, sepsis, multiple-trauma, 
burns, acute pancreatitis, cardiopulmonary bypass [CPB], 
and drug overdose) is present in critically ill patients un-
dergoing cardiac surgery with CPB, the consensus defini-
tion name for such cases is possible TRALI (10).
Conventional definition broadened with the criteria by 
Marik and Corwin (21) was used, including patients with 
preexisting respiratory problems that worsened after trans-
fusion and expanded monitoring time to up to 24 hours af-
ter each transfusion to discover the cases of “delayed TRALI 
syndrome.”
The following data were collected by an electronic data tool 
developed for this study as a web-based application: demo-
graphic characteristics, laboratory blood values (preopera-
tive and perioperative), and underlying patient characteris-
tics including admission diagnosis, body mass index (BMI), 
American Association of Anesthesiology (ASA) score, comor-
bidities, data on fluid balance, ventilation time, and ICU stay.
We also collected the following transfusion-related data: 
type of blood components and number of transfused RBC, 
plasma, and platelet units. Since in Croatia female donors 
are excluded, all plasma units were prepared from male do-
nors and all platelet concentrates were prepared from four 
pooled buffy coats and resuspended in plasma from male 
donors. All RBC components were leukoreduced by post-
storage filtration (<1 × 106 white blood cells per unit).
The following surgery-related data were collected: duration 
of surgery and duration of CPB.
We performed sample size calculation (22,23) and aimed to 
include 100 patients with respiratory worsening complying 
to the inclusion and exclusion criteria. All included patients 
were followed up until their final discharge from the ICU.
statistical analysis
Normality of distribution was tested by Kolmogorov-
Smirnov test, and the appropriate parametric or nonpara-
metric tests were used to analyze between-group differ-
ences. Binary logistic regression was performed to assess 
the impact of a number of factors on the likelihood that Figure 1. Flow diagram of patient groups.
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patients had possible TRALI. P values below 0.05 were con-
sidered significant. Data analysis was performed using STA-
TISTICA version 10 (StatSoft Inc., Tulsa, OK, 2011).
resulTs
Respiratory worsening was observed in 101 patients and 
ALI in 42 patients. Possible TRALI, monitored for up to 24 
hours after transfusion, was observed in 32/262 (12.2%) pa-
tients. ALI, but with no possibility for TRALI was observed 
in 10 patients because of other differential diagnoses. Clas-
sic TRALI developed within 6 hours of transfusion in 22/32 
possible TRALI patients and delayed TRALI (between 6 and 
24 hours) in 10/32 possible TRALI patients.
Patient-related risk factors
On admission, when compared to the control group pa-
tients who developed TRALI had a higher rate of high ASA 
scores, respiratory comorbidity (43.8% vs 15.5%, lower ad-
mission hemoglobin (105.5 ± 29.2 vs 125.6 ± 21.8), lower 
admission platelet count (169.4 ± 145.3 vs 217.5 ± 92.4), and 
lower admission prothrombin time (0.7 ± 0.2 vs 0.9 ± 0.2) 
(P < 0.001 all) (Table 1).
surgery-related risk factors
Patients who developed possible TRALI had longer dura-
tion of surgery (444.4 ± 103.1 vs 296.3 ± 57.3) and longer 
duration of CPB (250.6 ± 51 vs 131.3 ± 31.13) (P < 0.001 
both) (Table 1). Predictive value of CPB duration for the oc-
currence of TRALI was assessed using receiver operating 
characteristic (ROC) curve. ROC area under the curve (AUC) 
was 0.94, indicating that CPB time could be a powerful pre-
dictor of TRALI occurrence. Based on the model, the CPB 
cut-off value of 178 minutes had 90% sensitivity and 90% 
specificity in prediction of possible TRALI.
Transfusion-related risk factors
Compared with transfused controls without ALI, patients 
with possible TRALI received a higher total number of 
blood transfused units (median 14, range [3.5-18] vs 2.5 
[1.5-5]), RBC units (4 [2.5-6] vs 2 [1-3]), plasma units (5 [0-6] 
vs 0 [0-2]), and platelet units (0 [0-8] vs 0 [0-0]) (P < 0.001 
all). RBC storage time did not differ between the groups 
(Table 2). Out of 1349 total transfused blood units, 732 
(54.3%) were leukocyte-depleted RBC, 361 (26.8%) plasma, 
and 256 (19.0%) platelets.
Binary logistic regression
Binary logistic regression was performed to assess the 
impact of a number of factors on the likelihood that pa-
tients had possible TRALI. Out of the 8 independent vari-
ables assessed in the initial testing (age, sex, BMI, ASA 
score, respiratory comorbidity, total number of transfused 
blood units, duration of surgery, and duration of CPB), 5 
TaBle 1. Patient characteristics, clinical data, and transfusion-related acute lung injury (Trali) risk factors in patients with Trali and 
transfused controls without ali on admission
Parameter Transfused controls (without ali) Patients with possible Trali P
age (years; mean ± sd)  66.3 ± 10.28  62.6 ± 10.85 0.064
Male sex, n (%) 138 (62.7)  24 (75.0) 0.176
Body mass index (kg/m2; mean ± sd)  27.9 ± 4.51  28.4 ± 4.05 0.542
asa score, n (%):
II-III 183 (84.7)  19 (59.4) <0.001
IV-V  33 (15.3)  13 (40.6)
History of comorbidity, n (%):
cardiologic 213 (96.8)  30 (93.8) 0.382
respiratory  34 (15.5)  14 (43.8) <0.001
urologic  22 (10.0)   6 (18.8) 0.141
hepatic  29 (13.2)   3 (9.4) 0.546
metabolic 101 (45.9)  13 (40.6) 0.575
Hemoglobin (g/l; mean ± sd) 125.6 ± 21.8 105.5 ± 29.2 <0.001
Platelet count (n ×109/l; mean ± sd) 217.5 ± 92.4 169.4 ± 145.3 <0.001
Prothrombin time (mean ± sd)   0.9 ± 0.2   0.7 ± 0.2 <0.001
duration of surgery (min; mean ± sd) 296.3 ± 57.3 444.4 ± 103.1 <0.001
duration of CPB (min; mean ± sd) 131.3 ± 31.1 250.6 ± 51 <0.001
*abbreviations: sd – standard deviation; CPB – cardiopulmonary bypass; asa – american society of anesthesia classification.
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variables showed significant results (P < 0.01): ASA score 
(odds ratio [OR] 2.79; 95% confidence interval [CI] 1.38-
5.65), respiratory comorbidity (OR 4.25; 95% CI 1.93-9.36), 
total number of transfused blood units (OR 1.18; 95% 
CI 1.11-1.24), duration of surgery (OR 1.02; 95% CI 1.02-
1.03), and duration of CPB (OR 1.05; 95% CI 1.04-1.07). 
These variables were included in the multiple regression 
model. Using forward and backward selection approach-
es, some variables were dropped from the final model, 
which in the end included only 2 variables (total number 
of blood transfused units and duration of CPB). The model 
containing these 2 predictors was significant (χ2 = 128.6, 
P < 0.001), indicating that it was able to distinguish be-
tween the patients with and without TRALI. The model 
as a whole explained 77.8% (Nagelkerke R2, null adjusted) 
of the variance in symptomatology, correctly classified 
95.0% of cases, and demonstrated excellent goodness 
of fit of 0.839 (Hosmer and Lemeshow). Two variables in-
cluded in the model made a unique, significant contribu-
tion to the model: total number of transfused blood units 
(OR 1.23; 95% CI 1.10-1.37; P < 0.001) and duration of CPB 
(OR 1.08; 95% CI 1.05-1.11; P < 0.001).
The measurement of SaO2 with pulse oximetry indicated 
that respiratory function deterioration did not prove suffi-
cient for the ALI diagnosis as a prerequisite for clinical sus-
picion of possible TRALI (the value of SaO2 was not <90% 
at any point of measurement) (Figure 2). A significant de-
crease in the post-transfusion PaO2/FiO2 ratio was ob-
served in possible TRALI patients, along with a significant 
post-transfusion increase in transfused controls without 
ALI (Figure 2). Possible TRALI patients had a significantly 
longer ICU length of stay (hours) (median 96.5, range [31.5-
152.4] vs 29.1 [28.0-66.1]; P < 0.001).
disCussion
The main findings of our study were as follows: 1) the in-
cidence of possible TRALI was relatively high ; 2) patient-
related risk factors included higher ASA scores, respiratory 
TaBle 2. Transfusion data on patients with transfusion-related acute lung injury (Trali) and transfused controls without ali
Parameter (median, range) Transfused controls (without ali) Patients with possible Trali P
Total number of transfused blood units 2.5 (1.5-5) 14 (3.5-18) <0.001
Number of RBC transfusions (units) 2 (1-3)  4 (2.5-6) <0.001
Mean RBC age in days (mean ± standard deviation) 7.8 ± 3.19  7.3 ± 2.37 0.394
Number of plasma transfusions (units) 0 (0-2)  5 (0-6) <0.001
Number of platelet transfusions (units) 0 (0-0)  0 (0-8) <0.001
*abbreviations: rBC – red blood cell concentrates.
Figure 2. arterial oxygen saturation (sao2) (A) and partial pressure of arterial oxygen/fraction of inspired oxygen (PaO2/Fio2) ratio 
(B) before and after blood transfusion (Tx).
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comorbidity, lower admission hemoglobin, platelet count, 
and prothrombin time; 3) surgery-related risk factors in-
cluded longer duration of surgery and CPB; 4) transfusion 
related risk factors included higher total number of blood 
units, RBC, plasma, and platelet units; and 5) measuring 
PaO2/FiO2 ratio for an extended period of time post-trans-
fusion helped detect lung injury.
This study showed that worsening respiratory status in car-
diac surgery patients categorized as possible TRALI within 
24 hours of transfusion occurred in 12.2% of cases, which is 
higher than previously observed in general hospital popu-
lation (24-26). The strength of this study lies in its prospec-
tive design, whereas most other reports on this subject 
are retrospective and comprise reports to blood banks on 
general hospital population (24,26,27).
The incidence of possible TRALI in this study was compa-
rable to studies on TRALI in non surgical critically ill patients. 
For example, Gajic et al (19) reported on respiratory wors-
ening in 8% of patients who developed ALI within 6 hours 
of transfusion, while Benson et al reported a 15% incidence 
of TRALI in critically ill patients with end-stage liver disease 
(28). On the other hand, it was higher than 2.4% incidence in 
cardiac surgery patients reported by Vlaar et al (29-31). This 
difference could be ascribed to different monitoring time, 
ie, 6 hours in the study by Vlaar et al vs 24 hours in our study. 
The prolonged monitoring time to up to 24 hours could be 
perceived as a strong point of the present study. The us-
age of the expanded definition of TRALI (21) to find “delayed 
TRALI syndrome” cases is supported by the fact that a con-
siderable proportion of patients (10/32) developed respira-
tory worsening after standard 6-hour time frame. Therefore, 
we suggest monitoring for possible TRALI in cardiac surgery 
patients for more than the standard 6 hours (10).
Similar to studies in critically ill patients (19) and cardiac 
surgery patients (29-31), in our study more severely ill pa-
tients were at a higher risk of possible TRALI. Gajic et al 
demonstrated worsening of the existing ALI after trans-
fusion in 11.6% of patients (19), which is in line with our 
observation that pre-transfusion respiratory comorbidity 
poses a risk for possible TRALI. This fact indicates that phy-
sicians should reconsider using transfusion therapy in pa-
tients with impaired respiratory function.
Our data on the duration of surgery and CPB as risk factors 
for possible TRALI are similar to the findings of Vlaar et al, 
who showed the risk of TRALI to be associated with a lon-
ger clamp-, pump-, and surgery time (29,31). A proportion 
of alterations in lung function may be attributed to surgi-
cal factors (eg, hemidiaphragm paresis with concomitant 
atelectasis, wound pain, etc). There are multiple possible 
pathophysiological mechanisms by which CPB causes lung 
injury, eg, endothelial cell swelling, plasma, and protein ex-
travasation into the interstitial tissue, release of proteolytic 
enzymes, congestion of the alveoli with plasma and RBC, 
inflammatory reaction, and neutrophil priming (32).
In our study, respiratory worsening in cardiac surgery pa-
tients was associated with RBC, plasma, and platelet trans-
fusion in a dose-dependent manner. This is consistent with 
previous studies in cardiac critically ill patients (29,31). The 
Blood Banks in Croatia follow the policy of male exclusive 
plasma as a strategy to reduce the risk of TRALI. However, 
in critically ill patients even a low volume of antibody titer 
can be sufficient to initiate TRALI (15).
Clinical diagnosis of TRALI is made by exclusion of other 
differential diagnoses. Differential diagnoses were estab-
lished on patient history, physical examination, echocar-
diogram, electrocardiogram, biomarkers of myocardial 
injury, chest radiographs, fluid balance, and data from he-
modynamic invasive monitoring. Binary logistic regression 
analysis confirmed that a higher total number of trans-
fused blood units and longer duration of CPB were the risk 
factors for possible TRALI, which is in accordance with the 
studies by Vlaar et al in cardiac surgery patients (29,31).
Our study showed the PaO
2/FiO2 ratio was more sensitive 
than Sao2 pulse oximetry measurement for diagnosis of ALI 
(as a prerequisite for diagnosis of possible TRALI). There-
fore, we suggest that clinicians observe PaO2/FiO2 ratio af-
ter transfusion. Their attention should be focused on the 
patient group where “paradoxical” worsening in the mea-
sured PaO2/FiO2 values develops post-transfusion to iden-
tify patients that are more likely to develop possible TRALI.
Our study had some limitations. The results reflect a single 
center cardiothoracic surgical ICU in a tertiary care hospi-
tal, and although internal validity may have been high, ex-
ternal validation was limited and the sample size was rel-
atively small. Moreover, our data could not be compared 
with other cardiac surgery centers in Croatia. Therefore, a 
larger multicenter study should be conducted. Another 
potential drawback is that monitoring for TRALI lasted for 
up to 24 hours post-transfusion and missed some mild 
cases that developed later. Due to organizational and 
economic reasons during the study period, laboratory 
testing for possible TRALI was limited, which is why it 
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was considered that possible TRALI was a clinical diagnosis 
for which no exact confirmatory tests were available.
In conclusion, to our knowledge, this is the first study that 
reported that the post-transfusion PaO2/FiO2 ratio (consid-
ered a marker of lung injury) decreased in possible TRALI 
patients and increased in transfused controls without ALI. 
It also showed that the total number of transfused blood 
units and duration of cardiopulmonary bypass were risk 
factors for possible TRALI. In order to identify and prevent 
more possible TRALI cases, clinicians should proactively do 
serial monitoring of respiratory worsening by measuring 
PaO2/FiO2 ratio for an extended period of time (24 hours) 
post-transfusion in cardiac surgery patients.
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